Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunome (IMNM)
NASDAQ:IMNM
Immunome (IMNM) Ownership - Who Owns Immunome?
155 Followers
Immunome (IMNM) Ownership Overview
5.34% Insiders
9.84% Mutual Funds
7.42% Other Institutional Investors
77.40% Public Companies and
Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail and individual investors. Approximately 17.26% of the company’s stock is owned by Institutional Investors, 5.34% is owned by Insiders and 77.40% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 04, 2023 | Clay Siegall President And Ceo,director | Bought | $999996 |
| Oct 04, 2023 | Bruce Turner Chief Strategy Officer | Bought | $249993 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $267 | |
| Dec 31, 2023 | Bought | $9874944 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,021,414 | Institution | 3.37% | 31,554,273 | |
| 1,923,351 | Institution | 3.21% | 30,023,509 | |
| 1,627,489 | Institution | 2.72% | 25,405,103 | |
| 922,892 | Institution | 1.54% | 14,406,344 | |
| 831,551 | Institution | 1.39% | 12,980,511 | |
| 739,382 | Institution | 1.23% | 11,541,753 | |
| 642,841 | Institution | 1.07% | 10,034,748 | |
| 376,813 | Institution | 0.63% | 5,882,051 | |
| 213,000 | Institution | 0.36% | 3,324,930 | |
| 201,455 | Institution | 0.34% | 3,144,713 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,021,414 | Institution | 3.37% | 31,554,273 | |
| 1,627,489 | Institution | 2.72% | 25,405,103 | |
| 831,551 | Institution | 1.39% | 12,980,511 | |
| 739,382 | Institution | 1.23% | 11,541,753 | |
| 376,813 | Institution | 0.63% | 5,882,051 | |
| 201,455 | Institution | 0.34% | 3,144,713 | |
| 22,730 | Institution | 0.04% | 354,815 | |
| 16,569 | Institution | 0.03% | 258,642 | |
| 16,233 | Institution | 0.03% | 253,397 | |
| 14,246 | Institution | 0.02% | 222,380 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,324,141 | Institution | 2.21% | 32,679,800 | |
| 599,210 | Institution | 1.00% | 14,788,503 | |
| 578,528 | Institution | 0.97% | 9,030,822 | |
| 64,313 | Institution | 0.11% | 1,003,926 | |
| 46,350 | Institution | 0.08% | 723,524 | |
| 43,230 | Institution | 0.07% | 674,820 | |
| 18,239 | Institution | 0.03% | 282,705 | |
| 4,300 | Institution | <0.01% | 66,650 | |
| 1,602 | Institution | <0.01% | 14,402 |
FAQ
Who Owns Immunome (IMNM)?
According to the latest TipRanks data, approximately 7.42% of the company's stock is held by institutional investors, 5.34% is held by insiders, and 77.40% is held by retail investors.
What percentage of Immunome (IMNM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.42% of Immunome (IMNM) stock is held by institutional investors.
What percentage of Immunome (IMNM) stock is held by retail investors?
According to the latest TipRanks data, approximately 77.40% of Immunome (IMNM) stock is held by retail investors.
Who owns the most shares of Immunome (IMNM)?
Fidelity Mt. Vernon Street Trust owns the most shares of Immunome (IMNM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.